Dopamine receptors in brain and periphery
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aellig, 1977, Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration in man, Int. J. Clin. Pharmac., 15, 106
Amlaiky, 1986, Identification of the binding subunit of the D1-dopamine receptor by photoaffinity crosslinking, 45, 322
Amlaiky, 1985, Photoaffinity labeling of the D2-dopamine receptor using a novel high affinity radioiodinated probe, J. biol. Chem., 260, 1983, 10.1016/S0021-9258(18)89498-4
Amlaiky, 1984, A novel radioiodinated high affinity ligand for the D2-dopamine receptor, Fed. Eur. Biochem. Soc., 176, 436, 10.1016/0014-5793(84)81213-2
Andén, 1964, Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum, Life Sci., 3, 149, 10.1016/0024-3205(64)90196-1
Andén, 1967, Evidence for dopamine receptor stimulation by apomorphine, J. Pharm. Pharmac., 19, 627, 10.1111/j.2042-7158.1967.tb09604.x
Andersen, 1986, Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivo, Eur. J. Pharmac., 120, 143, 10.1016/0014-2999(86)90656-4
Andersen, 1985, A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum, Life Sci., 37, 1971, 10.1016/0024-3205(85)90028-1
Apud, 1985, Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat, Eur. J. Pharmac., 112, 187, 10.1016/0014-2999(85)90495-9
Arnett, 1983, Specific binding of [11C]spiroperidol in rat brain in vivo, J. Neurochem., 40, 455, 10.1111/j.1471-4159.1983.tb11304.x
Arnett, 1985, [18F-N-methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain, Life Sci., 36, 1359, 10.1016/0024-3205(85)90041-4
Arnett, 1985, Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography, J. Neurochem., 44, 835, 10.1111/j.1471-4159.1985.tb12891.x
Arnt, 1985, Differential effects of dopamine D-1 and D-2 agonists and antagonists in 6-hydroxy-dopamine-lesioned rats, 60
Arnt, 1985, Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats, Eur. J. Pharmac., 113, 79, 10.1016/0014-2999(85)90345-0
Arnt, 1983, Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers, Psychopharmacology, 81, 199, 10.1007/BF00427262
Arnt, 1984, Effects of S(+)-3-phenethyl-PP, a putative dopamine autoreceptor agonist with greater autoreceptor selectivity than 3-PPP enantiomers, Eur. J. Pharmac., 102, 91, 10.1016/0014-2999(84)90341-8
Arnt, 1984, Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions, Eur. J. Pharmac., 102, 349, 10.1016/0014-2999(84)90267-X
Bacopoulos, 1982, Dopamine receptors in rat brain regions, 31, 3085
Bacopoulos, 1983, [3H]dopamine binds to D-1 and D-2 receptors in rat striatum, Eur. J. Pharmac., 87, 353, 10.1016/0014-2999(83)90353-9
Bacopoulos, 1984, Dopaminergic 3H-agonist receptors in rat brain, 34, 307
Baldessarini, 1976, Mechanisms underlying tardive dyskinesia, 433
Baron, 1985, Dopaminergic receptor sites in human brain: Positron emission tomography, Neurology, 35, 16, 10.1212/WNL.35.1.16
Baron, 1983, An in vivo study of the dopaminergic receptors in the brain of man using 11C-pimozide and positron emission tomography, 337
Barone, 1985, Characterization of [3H]zetidoline binding to rat striatal membranes, J. Pharma. Pharmac., 37, 180, 10.1111/j.2042-7158.1985.tb05036.x
Barone, 1985, Different effects of D-1 and D-2 agonists in rats with unilateral striatal lesions, Soc. Neurosci. Abstr., 11, 47
Baudry, 1977, In vivo binding of 3H-pimozide in mouse striatum: Effects of dopamine agonists and antagonists, Life Sci., 21, 1163, 10.1016/0024-3205(77)90116-3
Baudry, 1979, 3H-Domperidone: A selective ligand for dopamine receptors, Naunyn-Schmiedeberg's Arch. Pharmac., 308, 231, 10.1007/BF00501387
Billard, 1984, Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum, Life Sci., 35, 1885, 10.1016/0024-3205(84)90540-X
Blanchard, 1980, The use of thioproperazine, a phenothiazine derivative, as a ligand for neuroleptic receptors I. In vitro studies, Biochem. Pharmac., 29, 2933, 10.1016/0006-2952(80)90040-4
Bockaert, 1977, Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra, Adv. Biochem. Psychopharmac., 16, 29
Bondy, 1985, Binding of 3H-spiperone to human lymphocytes: A biological marker in schizophrenia?, Psychiat. Res., 15, 41, 10.1016/0165-1781(85)90038-1
Borgundvaag, 1985, Dopamine inhibition of anterior pituitary adenylate cyclase is mediated through the high-affinity state of the D2 receptor, Life Sci., 37, 379, 10.1016/0024-3205(85)90509-0
Boyce, 1985, SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors, Biochem. Pharmacol., 34, 1665, 10.1016/0006-2952(85)90632-X
Breese, 1985, Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by l-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine, J. Pharmac. exp. Ther., 235, 287
Breese, 1985, SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons, Eur. J. Pharmac., 113, 109, 10.1016/0014-2999(85)90349-8
Brodde, 1982, Vascular dopamine receptors: demonstration and characterization by in vitro studies, Life Sci., 31, 289, 10.1016/0024-3205(82)90406-4
Brown, 1973, Influence of neuroleptic drugs and apomorphine on dopamine-sensitive adenylate cyclase of retina, J. Neurochem., 21, 477, 10.1111/j.1471-4159.1973.tb04268.x
Brown, 1976, Dopamine/neuroleptic receptors in basal hypothalamus and pituitary, Endocrinology, 99, 1407, 10.1210/endo-99-5-1407
Bruderlein, 1975, Neuroleptic agents of the benzo-cycloheptapyrido-isoquinoline series. 1. Syntheses and stereochemical and structural requirements of activity for butaclamol and related compounds, J. Med. Chem., 18, 185, 10.1021/jm00236a016
Bucher, 1975, Dopamine- and apomorphine-sensitive adenylate cyclase in homogenates of rabbit retina, Naunyn-Schmiedeberg's Arch. Pharmac., 288, 103, 10.1007/BF00501818
Bunney, 1973, Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity, J. Pharmac. exp. Ther., 185, 560
Burt, 1976, Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain, Molec. Pharmac., 12, 631
Burt, 1976, Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes, Molec. Pharmac., 12, 800
Burt, 1976, Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain, Science, N.Y., 196, 326, 10.1126/science.847477
Buylaert, 1978, The receptor mediating the apomorphine vasodilation in the hindleg of the dog, J. Pharm. Pharmac., 30, 113, 10.1111/j.2042-7158.1978.tb13174.x
Cannon, 1978, Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of 3H-haloperidol to neuroleptic receptors in the rat striatum, Biochem. Pharmac., 27, 1417, 10.1016/0006-2952(78)90094-1
Cannon, 1985, Synthesis and dopaminergic activity of (R)- and (S)-4-hydroxy-2-di-n-propylaminoindan, J. Med. Chem., 28, 515, 10.1021/jm00382a024
Cannon, 1976, Centrally acting emetics. 10. Rigid dopamine congeners derived from octahydrobenzo(f)quinoline, J. Med. Chem., 19, 987, 10.1021/jm00230a001
Cannon, 1978, Preparation and biological actions of some symmetrically N,N-di-substituted dopamines, J. Med. Chem., 21, 248, 10.1021/jm00201a002
Cannon, 1984, 6-Hydroxy-4-[2-(di-n-propylamino)ethyl]indole: Synthesis and dopaminergic actions, J. Med. Chem., 27, 386, 10.1021/jm00369a026
Carlsson, 1975, Receptor-mediated control of dopamine metabolism, 49
Carlsson, 1977, Dopaminergic autoreceptors: Background and implications, Adv. Biochem. Psychopharmac., 16, 439
Carlsson, 1963, Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain, Acta Pharmac. Toxic, 20, 140, 10.1111/j.1600-0773.1963.tb01730.x
Cassano, 1965, Distribution of 35S-chlorpromazine in cat brain, Arch. int. Pharmacodyn., 156, 48
Cheng, 1973, Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction, Biochem. Pharmac., 22, 3099, 10.1016/0006-2952(73)90196-2
Chi, 1986, 3-N-(2-[18F]fluoroalkyl)-spiperone: synthesis of N-alkylation with olefin halofluorination products and preliminary biodistribution studies
Christensen, 1984, Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics, Life Sci., 34, 1529, 10.1016/0024-3205(84)90607-6
Clement-Cormier, 1974, Dopamine-sensitive adenylate cyclase in mammalian brain: A possible site of action of antipsychotic drugs, 71, 1113
Clement-Cormier, 1977, Adenylate cyclase from various dopaminergic areas of the brain and the action of antipsychotic drugs, Biochem. Pharmac., 26, 1719, 10.1016/0006-2952(77)90151-4
Closse, 1980, Characterization of 3H-bromocriptine binding to calf caudate membranes, 463
Closse, 1985, [3H]205–501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors, J. Neural Transm., 62, 231, 10.1007/BF01252239
Closse, 1976, Dihydroergotamine binding to rat brain membranes, Life Sci., 19, 1851, 10.1016/0024-3205(76)90117-X
Comar, 1979, Brain distribution and kinetics of 11C-chlorpromazine in schizophrenics: positron emission tomography studies, Psychiat. Res., 1, 23, 10.1016/0165-1781(79)90024-6
Coward, 1983, Differential modification of apomorphine-induced biphasic circling behaviour in 6-hydroxydopamine lesioned rats by neuroleptic agents, Progr. Neuropsychopharmac. Biol. Psychiat. Suppl., 104
Crawley, 1983, Dopamine receptors displayed in living human brain with 77Br-p-bromospiperone, Lancet, ii, 975, 10.1016/S0140-6736(83)90497-X
Creese, 1985, Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390, Eur. J. Pharmac., 109, 127, 10.1016/0014-2999(85)90549-7
Creese, 1985, The effects of chronic SCH 23390 treatment on the biochemical and behavioral properties of D-1 and D-2 dopamine receptors, 15
Creese, 1979, 3H-N-n-propylnorapomorphine: A novel agonist ligand for central dopamine receptors, Eur. J. Pharmac., 56, 411, 10.1016/0014-2999(79)90274-7
Creese, 1978, Dopamine receptor binding: Specificity, localization and regulation by ions and guanyl nucleotides, Life Sci., 23, 495, 10.1016/0024-3205(78)90160-1
Cronin, 1982, Dopamine and bromocriptine inhibit cyclic AMP accumulation in the anterior pituitary: the effect of cholera toxin, J. Cyclic Nucleotide Res., 8, 267
Cross, 1980, Characteristics of 3H-cis-flupenthixol binding to calf brain membranes, Eur. J. Pharmac., 65, 341, 10.1016/0014-2999(80)90337-4
De Camilli, 1979, Dopamine inhibit adenylate cyclase in human prolactin-secreting pituitary adenomas, Nature, Lond., 278, 252, 10.1038/278252a0
De Keyser, 1985, D2 dopamine receptors in calf globus pallidus: agonist high- and low-affinity sites not regulated by guanine nucleotide, J. Neurochem., 45, 977, 10.1111/j.1471-4159.1985.tb04091.x
De Lean, 1982, Guanine nucleotides regulate both dopaminergic agonist and antagonist binding in porcine anterior pituitary, Endocrinology, 110, 1064, 10.1210/endo-110-3-1064
De Lean, 1982, Dopamine receptor of the porcine anterior pituitary gland, 22, 290
Digenis G. A., Vincent S. H., Kook C. S., Reiman R. E., Russ G. A. and Tilbury R. S. Tissue distribution studies of [18F]Haloperidol, [18F]-β-(4-fluorobenzoyl)propionic acid, and [82Br]bromoperidol by external scintigraphy. J. Pharmaceut. Sci.70, 985–989.
Di Paolo, 1979, Effects of estrogens on the characteristics of 3H-spiroperidol and 3H-RU 24213 binding in rat anterior pituitary gland and brain, Molec. Cell. Endocrin., 16, 99, 10.1016/0303-7207(79)90108-4
Dumbrille-Ross, 1985, Dopamine D1 and D2 receptor interactions, Soc. Neurosci. Abstr., 11, 716
Dumbrille-Ross, 1985, Separation of dopamine D1 and D2 receptors, Eur. J. Pharmac., 110, 151, 10.1016/0014-2999(85)90045-7
Eckert, 1970, Autoradiographic studies on the distribution of psychoactive drugs in the rat brain IV. 14C-Thioridazine, Int. Pharmacopsychiat., 4, 98, 10.1159/000468055
Enjalbert, 1983, Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary, Molec. Pharmac., 23, 576
Farde, 1985, Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography, 82, 3863
Farrokhzad, 1985, The synthesis of no-carrier-added and carrier-added 18F-labelled haloperidol, J. Labelled Comp. Radiopharmaceut., 22, 721, 10.1002/jlcr.2580220713
Fields, 1977, Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidol, Brain Res., 136, 578, 10.1016/0006-8993(77)90084-1
Flaim, 1985, Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum, Life Sci., 36, 1427, 10.1016/0024-3205(85)90049-9
Flaim, 1985, Characterization of agonist binding to D-1 receptors in rat striatum using the D-1 selective antagonist 3H-SKF R-83566, 44, 1832
Fletcher, 1985, SKF 38393 and apomorphine modify locomotion and exploration in rats placed on a holeboard by separate actions at dopamine D-1 and D-2 receptors, Eur. J. Pharmac., 117, 381, 10.1016/0014-2999(85)90014-7
Foley, 1985, Characteristics of [3H]-SKF 38393 binding to rat striatal D1 receptor sites, The Pharmacologist, 27, 240
Friedman, 1985, Positron tomography of a radio-brominated analog of the D1/DA, antagonist, SCH 23390, Eur. J. Pharmac., 108, 327, 10.1016/0014-2999(85)90459-5
Fujita, 1979, Binding of 3H-lisuride hydrogen maleate to striatal membranes of rat brain, Life Sci., 25, 969, 10.1016/0024-3205(79)90502-2
Fujita, 1985, Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor, Brain Res., 333, 231, 10.1016/0006-8993(85)91576-8
Fuxe, 1981, Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides, J. Neural Transm., 51, 3, 10.1007/BF01664003
Garau, 1978, Dopamine receptors: pharmacological and anatomical evidence indicate two distinct dopamine receptor populations are present in rat striatum, Life Sci., 23, 1745, 10.1016/0024-3205(78)90102-9
George, 1985, The functional state of the dopamine receptor in the anterior pituitary is in the high-affinity form, Endocrinology, 117, 690, 10.1210/endo-117-2-690
George, 1985, Dopamine D2 receptors in the anterior pituitary: A single population without reciprocal agonist/antagonist states, J. Neurochem., 44, 1168, 10.1111/j.1471-4159.1985.tb08740.x
George, 1985, Dopamine D2 receptors in brain and anterior pituitary recognize agonist and antagonist actions of (−)-3-PPP, J. Neural Transm., 64, 13, 10.1007/BF01259342
Gessa, 1985, Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390, Eur. J. Pharmac., 109, 269, 10.1016/0014-2999(85)90429-7
Goldberg, 1983, Differentiation of dopamine receptors in the periphery, 224
Goldberg, 1978, A comparison of the vascular dopamine receptor with other dopamine receptors, A. Rev. Pharmac. Toxic., 18, 57, 10.1146/annurev.pa.18.040178.000421
Goldstein, 1985, The pathophysiological functions mediated by D1 dopamine receptors, 15
Goldstein, 1985, SCH 23390: electrophysiological effects on A9 and A10 dopamine neurons, The Pharmacologist, 27, 197
Grigoriadis, 1984, The dopamine/neuroleptic receptor, Can. J. Neurol. Sci., 11, 108, 10.1017/S0317167100046242
Grigoriadis, 1985, Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide, J. Neurochem., 44, 1925, 10.1111/j.1471-4159.1985.tb07189.x
Grigoriadis, 1986, 3H-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain, Naunyn-Schmiedeberg's Arch. Pharmac., 332, 21, 10.1007/BF00633192
Gundlach, 1984, 125I-spiperone: a novel ligand for D2 dopamine receptors, Life Sci., 35, 1981, 10.1016/0024-3205(84)90479-X
Hall, 1983, Differential labelling of dopamine receptors in rat brain in vivo: comparison of [3H]piribedil, [3H]S 3608 and [3H]N,n-propylnorapomorphine, Eur. J. Pharmac., 87, 85, 10.1016/0014-2999(83)90053-5
Hall, 1985, Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain, Eur. J. Pharmac., 111, 191, 10.1016/0014-2999(85)90756-3
Hamblin, 1984, Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes, Biochem. Pharmac., 33, 877, 10.1016/0006-2952(84)90441-6
Hancock, 1984, Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol, Molec. Pharmac., 26, 439
Hauser, 1978, 3H-Clozapine binding to rat brain membranes, Life Sci., 23, 557, 10.1016/0024-3205(78)90034-6
Herrera-Marschitz, 1984, Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites, Eur. J. Pharmac., 98, 165, 10.1016/0014-2999(84)90587-9
Herrera-Marschitz, 1985, Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats, Eur. J. Pharmac., 109, 349, 10.1016/0014-2999(85)90395-4
Hess, 1986, Guanine nucleotide regulation of agonist interactions at [3H]SCH 23390-labeled D1 dopamine receptors in rat striatum, Eur. J. Pharmac., 121, 31, 10.1016/0014-2999(86)90389-4
Hicks, 1984, The 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain, Eur. J. Pharmac., 105, 339, 10.1016/0014-2999(84)90628-9
Hieble, 1985, Neuronal dopamine receptors of the rabbit ear artery: pharmacological characterization of the receptor, J. Auton. Pharmac., 5, 115, 10.1111/j.1474-8673.1985.tb00112.x
Hilditch, 1985, Peripheral dopamine receptor blockade by SCH 23390 and domperidone in vitro, Eur. J. Pharmac., 116, 171, 10.1016/0014-2999(85)90199-2
Horn, 1975, Structure-activity relations for neurotransmitter receptor agonists and antagonists, Vol. 2, 179
Horn, 1985, Synthesis and radioreceptor binding activity of N-0437, a new, extremely potent and selective D2 dopamine receptor agonist, Pharmaceutisch Weekblad Sci. Ed., 7, 208, 10.1007/BF02307578
Huff, 1982, Quantitative determination of dopamine receptor subtypes not linke to activation of adenylate cyclase in rat striatum, 79, 7561
Huff, 1985, Assay of dopamine receptors with [α-3H]Flupenthixol, J. Pharmac. exp. Ther., 232, 57
Humber, 1975, Neuroleptic agents or the benzocycloheptapyridoisoquinoline series, 11, 833
Hyttel, 1978, Effects of neuroleptics on 3H-haloperidol and 3H-cis (Z)-flupenthixol binding and on adenylate cyclase activity in vitro, Life Sci., 23, 551, 10.1016/0024-3205(78)90033-4
Hyttel, 1981, Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro, Life Sci., 28, 563, 10.1016/0024-3205(81)90150-8
Hyttel, 1983, SCH 23390-the first selective dopamine D-1 antagonist, Eur. J. Pharmac., 91, 153, 10.1016/0014-2999(83)90381-3
Hyttel, 1985, Dopamine D-1 and D-2 receptors, 139
Ilhan, 1986, Dopamine receptor agonistic activities of (R)- and (S)-enantiomers of 4-hydroxy-2-di-n-propyl-aminoindan in cat hearts, J. Pharm. Pharmac., 37, 364, 10.1111/j.2042-7158.1985.tb05086.x
Ilhan, 1986, Dopamine receptor stimulating and alpha adrenoceptor blocking actions of trans (CS-265) and cis (CS-263) isomers of nonhydroxylated N-propyl octahydrobenzo(f)quinoline, J. Pharmac. exp. Ther., 231, 361
Ilhan, 1986, Dopaminergic activity of a nonhydroxylated aminotetralin derivative (TL-68) on cat hearts, Arch. int. Pharmacodyn.
Ilhan, 1986, Evaluation of dopaminergic and alpha adrenergic activities of TL-99 in peripheral tissues in vitro, Arch. int. Pharmacodyn., 279, 17
Imbs, 1981, Renal vascular effects of dopaminomimetics, Vol. 1, 265
Imbs, 1983, Caractéristiqués pharmacologiques des récepteurs dopaminergiques renaux: perspectives therapeutiques, J. Pharmac., Paris, 14, 5
Iorio, 1983, SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems, J. Pharmac. exp. Ther., 226, 462
Israel, 1985, The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine, Endocrinology, 117, 1448, 10.1210/endo-117-4-1448
Itoh, 1984, The chemical basis for the blockade of the D-1 dopamine receptor by SCH 23390, Eur. J. Pharmac., 100, 119, 10.1016/0014-2999(84)90324-8
Iversen, 1976, Biochemical pharmacology of dopamine receptors in mammalian central nervous system, 35
Jackson, 1985, Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties, J. Neural Transm., 62, 219, 10.1007/BF01252238
Janssen, 1969, The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperol in rats, and its relationship with their neuroleptic activity, Arzneimittel-Forschung, 19, 199
Kaiser, 1982, Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, J. Med. Chem., 25, 697, 10.1021/jm00348a017
Karobath, 1975, Dopamin-Rezeptor-Blockade, ein möglicher Wirkungs-mechanismus antipsychotisch wirksamer Pharmaka, Pharmakopsych., 8, 151, 10.1055/s-0028-1094454
Karobath, 1974, Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain, 71, 2915
Kebabian, 1972, Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the “dopamine receptor”, 69, 2145
Kilpatrick, 1985, The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes, Eur. J. Pharmac., 107, 71, 10.1016/0014-2999(84)90093-1
Koch, 1983, Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites, Eur. J. Pharmac., 92, 279, 10.1016/0014-2999(83)90299-6
Köhler, 1985, Specific in vitro and in vivo binding of 3H-raclopride, 34, 2251
Koons, 1983, Antagonist properties of phentolamine at both presynaptic alpha2-adrenoceptors and presynaptic dopamine receptors using field stimulated right cat atria, Eur. J. Pharmac., 88, 311, 10.1016/0014-2999(83)90581-2
Kwant, 1969, The membrane concentration of a local anesthetic (chlorpromazine), Biochim. biophys. Acta, 183, 530, 10.1016/0005-2736(69)90167-9
Laduron, 1983, Commentary: Dopamine- sensitive adenylate cyclase as a receptor site, 224, 22
Laduron, 1977, Spiperone: A ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs, Biochem. Pharmac., 27, 317, 10.1016/0006-2952(78)90234-4
Lazareno, 1983, Effects of GTP on 3H-domperidone binding and its displacement by dopamine in rat striatal homogenates, J. Receptor Res., 3, 163, 10.3109/10799898309041931
Lee, 1977, Dopamine receptors in normal and schizophrenic human brains, Soc. Neurosci. Abstr., 3, 443
Lee, 1978, Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains, Nature, Lond., 274, 897, 10.1038/274897a0
Leff, 1984, Dopaminergic D-3 binding sites are not presynaptic autoreceptors, Nature, Lond., 306, 586, 10.1038/306586a0
Leff, 1985, Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists, 27, 171
Leff, 1985, Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum, 27, 184
Lew, 1985, Photoaffinity labeling and purification of solubilized D2 dopamine receptors, Eur. J. Pharmac., 113, 145, 10.1016/0014-2999(85)90359-0
Leysen, 1978, Spiperone: A ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding, Biochem. Pharmac., 27, 307, 10.1016/0006-2952(78)90233-2
Leysen, 1978, Serotonergic component of neuroleptic receptors, Nature, Lond., 272, 168, 10.1038/272168a0
Leysen, 1982, [3H]Ketanserin (R41468), a selective 3H-ligand for serotonin2 receptor binding sites, Molec. Pharmac., 21, 301
Lilly, 1983, D2 dopamine receptor purification using 3H-NCA: Identification of a 40,000 dalton binding protein, Soc. Neurosci. Abstr., 9, 30
Lin, 1981, [3H]Dihydroergocryptine binding to bovine striatal membranes defined by a low d-butaclamol concentration, Biochem. Pharmac., 30, 1305, 10.1016/0006-2952(81)90314-2
List, 1981, Resolution of the dopamine and serotonin receptor components of 3H-spiperone binding to rat brain regions, 78, 2620
List, 1982, 3H-Dopamine labelling of D3 dopaminergic sites in human, rat and calf brain, J. Neurochem., 39, 1363, 10.1111/j.1471-4159.1982.tb12579.x
List, 1982, Striatal binding of 3H-ADTN to two dopaminergic sites distinguished by their low and high affinity for neuroleptics, J. Neurosci., 2, 895, 10.1523/JNEUROSCI.02-07-00895.1982
Long, 1975, Inhibition of the sympathetic nervous system by 5,6-dihydroxy-2-dimethylamino tetralin (M-7), apomorphine and dopamine, J. Pharmac. exp. Ther., 192, 336
Long, 1979, Inhibitory receptors on the adrenergic nerve terminal
Loonen, 1978, Regional localization of halopemide, a new psychotropic agent, in the rat brain, Eur. J. Pharmac., 50, 403, 10.1016/0014-2999(78)90146-2
Mackenzie, 1985, Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum, Eur. J. Pharmac., 113, 159, 10.1016/0014-2999(85)90732-0
Madras, 1980, Solubilization of dopamine receptors from dog and human brains, 411
Madras, 1985, Drug potencies on partially purified brain D2 dopamine receptors, J. Neurochem., 44, 856, 10.1111/j.1471-4159.1985.tb12894.x
Markstein, 1978, The effect of bromocriptine on rat striatal adenylate cyclase and rat brain monoamine metabolism, J. Neurochem., 31, 1163, 10.1111/j.1471-4159.1978.tb06240.x
Martres, 1978, Characterization of 3H-domperidone binding on striatal dopamine receptors, Life Sci., 23, 1781, 10.1016/0024-3205(78)90108-X
Martres, 1985, Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand, Science, N.Y., 228, 752, 10.1126/science.3838821
Martres, 1985, Localisation and pharmacological characterisation of D-2 dopamine receptors in rat cerebral neocortex and cerebellum using [125I]iodosulpride, Eur. J. Pharmac., 118, 211, 10.1016/0014-2999(85)90131-1
Mazière, 1985, In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]Bromospiperone, Eur. J. Pharmac., 114, 267, 10.1016/0014-2999(85)90369-3
Mazière, 1984, 76Br-bromospiroperidol: A new tool for quantitative in-vivo imaging of neuroleptic receptors, Life Sci., 35, 1349, 10.1016/0024-3205(84)90391-6
McDonald, 1984, Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors, Molec. Cell. Endocrin., 36, 201, 10.1016/0303-7207(84)90037-6
Meller, 1985, Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, A selective D1 antagonist, Life Sci., 36, 1857, 10.1016/0024-3205(85)90159-6
Memo, 1985, Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells, Brain Res., 347, 253, 10.1016/0006-8993(85)90184-2
Mereu, 1985, SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine, Eur. J. Pharmac., 111, 393, 10.1016/0014-2999(85)90649-1
Meunier, 1982, The dopamine receptor in the intermediate lobe of the rat pituitary gland is negatively coupled to adenylate cyclase, Life Sci., 30, 963, 10.1016/0024-3205(82)90625-7
Miller, 1974, The action of neuroleptic drugs on dopamine-stimulated adenosine cyclic 3′,5′-monophosphate production in rat neostriatum and limbic forebrain, Molec. Pharmac., 10, 759
Miller, 1975, Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatum, J. Pharm. Pharmac., 27, 212, 10.1111/j.2042-7158.1975.tb09444.x
Miller, 1974, Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography, Nature, Lond., 250, 238, 10.1038/250238a0
Miller, 1974, Effects of chlorpromazine and some of its metabolites on the dopamine-sensitive adenylate cyclase of rat brain striatum, J. Pharm. Pharmac., 26, 142, 10.1111/j.2042-7158.1974.tb09243.x
Miller, 1976, Aporphines 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain, Eur. J. Pharmac., 35, 77, 10.1016/0014-2999(76)90302-2
Mir, 1983, Characterization of 3H-piflutixol binding to bovine caudate membranes and problems of defining specific binding, J. Neurochem., 41, S78
Mizuchi, 1982, Characteristics of [3H]sultopride binding to rat brain, Eur. J. Pharmac., 84, 51, 10.1016/0014-2999(82)90156-X
Moerlein, 1984, Specific in vivo binding of 77Br-brombenperidol in rat brain, Life Sci., 35, 1357, 10.1016/0024-3205(84)90392-8
Moerlein, 1984, Radiosynthesis of no-carrier-added 75,77Br-brombenperidol, J. Labelled Comp. Radiopharmaceut., 21, 875, 10.1002/jlcr.2580210911
Moerlein, 1985, Synthesis of high specific activity [75Br]- and [77Br]Bromperidol and tissue distribution studies in the rat, J. Med. Chem., 28, 1319, 10.1021/jm00147a035
Molloy, 1984, Dopaminergic behaviour stereospecifically promoted by the D1 agonist R-SK&F 38393 and selectivity blocked by the D1 antagonist SCH 23390, Psychopharmacology, 82, 409, 10.1007/BF00427697
Morelli, 1985, Catalepsy induced by SCH 23390 in rats, Eur. J. Pharmac., 117, 179, 10.1016/0014-2999(85)90602-8
Morgan, 1986, (3H)Fluphenazine binding to brain membranes
Morgan, 1977, Localization of a new neuroleptic in the pituitary gland of the rat, Experientia, 33, 1485, 10.1007/BF01918823
Mulder, 1985, Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranes, Eur. J. Pharmac., 112, 73, 10.1016/0014-2999(85)90240-7
Muller, 1976, Alterations in dopaminergic sensitivity in chronically pretreated rats, Soc. Neurosci. Abstr., 2, 874
Muller, 1977, Brain neurotransmitter receptors after longterm haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors, Life Sci., 21, 1751, 10.1016/0024-3205(77)90155-2
Munemura, 1980, The dopamine receptor in the intermediate lobe of the rat pituitary gland: pharmacological characterization, Endocrinology, 107, 1676, 10.1210/endo-107-6-1676
Nakajima, 1984, [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner, Molec. Pharmac., 26, 430
Nakatsuka, 1978, Labelling of neuroleptic butyrophenones. 1. Syntheses of haloperidol-14C and trifluperidol-14C, J. Labelled Comp. Radiopharmaceut., 14, 133, 10.1002/jlcr.2580140117
Neumeyer, 1985, Novel photoaffinity label for the dopamine D2 receptor: synthesis of 4-azido-5-iodo-2-methoxy-N-[1-(phenylmethyl)-4-piperidinyl] benzamide (Iodoazido-clebopride, IAC) and the corresponding 125I-labelled analogue, J. Med. Chem., 28, 405, 10.1021/jm00382a002
Niznik, 1985, Dopamine D2 receptors photolabeled by iodo-azido-clebopride, Neurosci. Lett., 55, 267, 10.1016/0304-3940(85)90446-X
Niznik, 1986, The dopamine D1 receptor: partial purification of a digitonin-solubilized receptor-guanine nucleotide binding complex, Biochem. Pharmac., 35, 2974, 10.1016/0006-2952(86)90496-X
Niznik, 1985, Dopamine D2 receptors are selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2, Naunyn-Schmiedeberg's Arch. Pharmac., 329, 333, 10.1007/BF00496365
Niznik, 1985, A photoaffinity ligand for dopamine D2 receptors: azidoclebopride, Molec. Pharmac., 27, 193
O'Boyle, 1984, Stereotypy induced by the D2 dopamine agonist RU24213 is blocked by the D2 antagonist R022-2586 and the D1 antagonist SCH 23390, Br. J. Pharmac.
O'Boyle, 1984, Selective and stereospecific interactions of R-SK&F with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390, Eur. J. Pharmac., 98, 433, 10.1016/0014-2999(84)90294-2
O'Boyle, 1985, Structural determinants of selective affinity for brain D-1 dopamine receptors within a series of 1-phenyl-1H-3-benzazepine analogues of SK&F 38398 and SCH 23390, Eur. J. Pharmac., 115, 291, 10.1016/0014-2999(85)90702-2
Ohlstein, 1985, SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors, Eur. J. Pharmac., 108, 205, 10.1016/0014-2999(85)90728-9
Ohlstein, 1985, The DA1 receptor agonist fenoldopam (SK&F 82526) is also an α2-adrenoceptor antagonist, Eur. J. Pharmac., 118, 321, 10.1016/0014-2999(85)90143-8
Oliva, 1984, Combined effects of vasoactive intestinal peptide and dopamine on adenylate cyclase in prolactin-secreting cells, Peptides, 5, 1067, 10.1016/0196-9781(84)90172-4
Onali, 1984, Striatal dopamine transmission: effects of selective blockade of D-1 receptors by SCH 23390, Soc. Neurosci. Abstr., 10, 238
Onali, 1985, SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neuron but fails to activate striatal tyrosine hydroxylase, Brain Res., 340, 1, 10.1016/0006-8993(85)90769-3
Onali, 1984, Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats, Eur. J. Pharmac., 99, 127, 10.1016/0014-2999(84)90445-X
Onali, 1985, Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum, Molec. Pharmac., 28, 138
Onali, 1981, Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary, 78, 6531
Owen, 1983, 77Br-p-bromospiperone: A ligand for in vivo labelling of dopamine receptors, Life Sci., 33, 765, 10.1016/0024-3205(83)90782-8
Pawlikowski, 1981, Effects of dopamine on cyclic AMP concentration in the anterior pituitary gland in vitro, J. Neural Transm., 50, 179, 10.1007/BF01249139
Peroutka, 1977, Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain, Neuropharmacology, 16, 549, 10.1016/0028-3908(77)90023-5
Peroutka, 1979, Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol, Molec. Pharmac., 16, 687
Pfaffinger, 1985, GTP-binding proteins couple cardiac muscarinic receptors to a K channel, Nature, Lond., 317, 536, 10.1038/317536a0
Piascik, 1981, Ca2+-dependent regulation of rat caudate nucleus adenylate cyclase and effects on the response to dopamine, Molec. Pharmac., 20, 319
Piriou, 1985, Benzamide potentiation of behavioral apomorphine-induced effects: mechanism involved, Experientia, 41, 1409, 10.1007/BF01950008
Plantjé, 1984, SCH 23390 blocks D-1 and D-2 dopamine receptors in rat neostriatum in vitro, Naunyn-Schmiedeberg's Arch. Pharmac., 327, 180, 10.1007/BF00500914
Plantjé, 1984, The effects of SCH 23390, YM 09151-2, (+)- and (−)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro, Eur. J. Pharmac., 105, 73, 10.1016/0014-2999(84)90650-2
Porceddu, 1985, Chronic blockade of D1 dopamine receptors increases 3H-SCH 23390 binding sites in the rat striatum, Soc. Neurosci. Abstr., 11, 456
Porceddu, 1985, [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors, Eur. J. Pharmac., 118, 367, 10.1016/0014-2999(85)90151-7
Pri-Bar, 1983, Tritium labelling of benzamide drugs, J. Labelled Comp. Radiopharmaceut., 20, 1153, 10.1002/jlcr.2580201004
Redouane, 1985, Photoaffinity labeling of D-2 dopamine binding subunits from rat striatum, anterior pituitary and olfactory bulb with a new probe, [3H]azidosulpride, Biochem. biophys. Res. Commun., 130, 1086, 10.1016/0006-291X(85)91727-9
Richelson, 1984, Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro, Eur. J. Pharmac., 103, 197, 10.1016/0014-2999(84)90478-3
Rosengarten, 1983, Acute neuroleptic induction of perioral movements in rats: mediation by the D1 dopamine receptor, Progr. Neuropsychopharmac. Biol. Psychiatr., 265
Roufogalis, 1976, Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists, Life Sci., 19, 927, 10.1016/0024-3205(76)90321-0
Saller, 1985, Dopamine receptor subtypes: In vivo biochemical evidence for functional interaction, Eur. J. Pharmac., 109, 297, 10.1016/0014-2999(85)90435-2
Sandrini, 1984, Dopamine receptors in the guinea-pig heart, 35, 1839
Sano, 1979, Dopamine receptors and dopamine-sensitive adenylate cyclase in canine caudate nucleus, Biochem. Pharmac., 28, 3617, 10.1016/0006-2952(79)90408-8
Scatton, 1985, Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SKF 38393, Eur. J. Pharmac., 111, 145, 10.1016/0014-2999(85)90128-1
Schmidt, 1980, Pharmacological characterization of renal vascular dopamine receptors, J. Cardiovasc. Pharmac., 2, 595, 10.1097/00005344-198009000-00009
Schmidt, 1982, Vasodilator effects of dopaminomimetics in the perfused rat kidney, Eur. J. Pharmac., 84, 61, 10.1016/0014-2999(82)90157-1
Schmidt, 1983, Blockade of dopamine receptors in the renal vasculature by isomers of flupenthixol and sulpiride, J. Cardiovasc. Pharmac., 5, 86, 10.1097/00005344-198301000-00013
Schmidt, 1984, Vascular effects of apomorphine and related compounds in the perfused rat kidney, Eur. J. Pharmac., 97, 75, 10.1016/0014-2999(84)90514-4
Schmidt, 1981, The vascular dopamine receptor: A review, J. Pharmac. (Paris), 12, 355
Schulz, 1985, SCH 23390 causes persistent antidopaminergic effects in vivo: evidence for longterm occupation of receptors, Life Sci., 16, 1941, 10.1016/0024-3205(85)90443-6
Seeman, 1972, The membrane actions of anesthetics and tranquilizers, Pharmac. Rev., 24, 583
Seeman, 1974, Comparison of pre-synaptic and post-synaptic theories of neuroleptic action, J. Pharmac. (Paris), 5, 91
Seeman, 1977, Anti-schizophrenic drugs: Membrane receptor sites of action, Biochem. Pharmac., 26, 1741, 10.1016/0006-2952(77)90340-9
Seeman, 1980, Brain dopamine receptors, Pharmac. Rev., 32, 229
Seeman, 1982, Nomenclature of central and peripheral dopaminergic sites and receptors, Biochem. Pharmac., 31, 2563, 10.1016/0006-2952(82)90700-6
Reference deleted.
Seeman, 1986
Seeman, 1975, Brain receptors for antipsychotic drugs and dopamine: Direct binding assays, 72, 4376
Seeman, 1985, Dopamine D2 receptor dissociation constant for spiperone: Identical values using 3H-labeled agonist or 3H-labeled antagonist, Biochem. Pharmac., 34, 4065, 10.1016/0006-2952(85)90388-0
Seeman, 1986, Selectivity of agonists and antagonists at D2 dopamine receptors compared to D1 and S2 receptors, Drug. Dev. Res., 9, 63, 10.1002/ddr.430090108
Seeman, 1984-1986, Functional states of dopamine receptors, 97
Seeman, 1976, Dopamine receptors in human and calf brains, using 3H-apomorphine and an antipsychotic drug, 73, 4354
Seeman, 1976, Antipsychotic drug doses and neuroleptic/dopamine receptors, Nature, Lond., 261, 717, 10.1038/261717a0
Seeman, 1974, The nerve impulse-blocking actions of tranquilizers, and the binding of neuroleptics to synaptosome membranes, J. Pharmac. exp. Ther., 190, 123
Seeman, 1983, Neuroleptics have identical potencies in human brain limbic and putamen regions, Eur. J. Pharmac., 94, 145, 10.1016/0014-2999(83)90452-1
Seeman, 1984, Bimodal distribution of dopamine receptor densities in brains of schizophrenics, Science, N.Y., 225, 728, 10.1126/science.6147018
Seeman, 1985, Conversion of dopamine D1 receptors from high to low affinity for dopamine, Biochem. Pharmac., 34, 151, 10.1016/0006-2952(85)90116-9
Seeman, 1984, Dopamine receptor parameters detected by 3H-spiperone depend on tissue concentration: analysis and examples, J. Neurochem., 43, 221, 10.1111/j.1471-4159.1984.tb06700.x
Seeman, 1985, Dopamine D2 receptor binding sites for agonists: A tetrahedral model, Molec. Pharmac., 28, 391
Seeman, 1974, Dopamine receptor-block and nigral fiber impulse-blockade by major tranquilizers, 33, 246
Seeman, 1975, Tranquilizer receptors in rat striatum, Soc. Neurosci. Abstr., 1, 405
Seeman, 1979, Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors, Eur. J. Pharmac., 55, 137, 10.1016/0014-2999(79)90385-6
Seiler, 1982, Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor, Molec. Pharmac., 22, 281
Setler, 1978, The central effects of a novel dopamine agonist, Eur. J. Pharmac., 50, 419, 10.1016/0014-2999(78)90148-6
Sharabi, 1976, Inhibition of the sympathetic nervous system by a series of heterocyclic congeners of dopamine, J. Pharmac. exp. Ther., 199, 630
Shetty, 1981, Synthesis of deuterium labelled trifluoperazine, J. Labelled Comp. Radiopharmaceut., 18, 1633, 10.1002/jlcr.2580181109
Sibley, 1983, Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors, Molec. Pharmac., 23, 585
Sidhu, 1985, An iodinated ligand identifying the D-1 dopamine receptor, Eur. J. Pharmac., 113, 437, 10.1016/0014-2999(85)90093-7
Sokoloff, 1985, The use of [3H](−)-DO 710 as selective dopaminergic ligand for binding and autoradiographic studies, Eur. J. Pharmac., 107, 243, 10.1016/0014-2999(85)90064-0
Sokoloff, 1985, 3H-(−)DO 710 discriminates guanine nucleotide sensitive and insensitive dopamine binding sites, Naunyn-Schmiedeberg's Arch Pharmac., 329, 236, 10.1007/BF00501874
Spano, 1981, 3H-Lisuride, a potent dopaminergic ergot derivative, labels D2-dopamine receptors, Soc. Neurosci. Abstr., 7, 125
Spano, 1978, Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system, Adv. Biochem. Psychopharmac., 19, 155
Stefanini, 1980, Sodium-dependent interaction of benzamides with dopamine receptors, Brain Res., 198, 229, 10.1016/0006-8993(80)90360-1
Reference deleted.
Reference deleted.
Steinsland, 1978, Dopaminergic inhibition of adrenergic neurotransmission as a model for studies on dopamine receptor mechanisms, Science, N.Y., 199, 443, 10.1126/science.22933
Steinsland, 1978, Relative potencies of agonists acting on dopamine receptors
Stoof, 1985, Opposing roles for D-1 and D-2 dopamine receptors in regulating the excitability of growth hormone-producing cells in the snail lymnaea stgnalis, Eur. J. Pharmac., 106, 431, 10.1016/0014-2999(84)90735-0
Stoof, 1981, Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum, Nature, Lond., 294, 366, 10.1038/294366a0
Stoof, 1982, Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat striatum, Brain Res., 250, 263, 10.1016/0006-8993(82)90420-6
Stoof, 1984, Two dopamine receptors: biochemistry, physiology and pharmacology, Life Sci., 35, 2281, 10.1016/0024-3205(84)90519-8
Swennen, 1982, Physiological concentrations of dopamine decrease adenosine 3′,5′-monophosphate levels in cultured rat anterior pituitary cells and enriched populations of lactotrophs: evidence for a causal relationship to inhibition of prolactin release, Endocrinology, 111, 398, 10.1210/endo-111-2-398
Taylor, 1974, Displacement of bound 14C-fluphenazine by biogenic amines and antipsychotic drugs in homogenates of brain tissue, Nature, Lond., 252, 238, 10.1038/252238a0
Theodoru, 1979, Specific binding of [3H]sulpiride to rat striatal preparations, J. Pharm. Pharmac., 31, 424, 10.1111/j.2042-7158.1979.tb13545.x
Titeler, 1985, Properties of 3H-N-methyl spiperone binding to human and rat D2 and 5-HT2 receptors in vitro, Soc. Neurosci. Abstr., 11, 888
Titeler, 1979, Selective labeling of different dopamine receptors by a new agonist 3H-ligand: 3H-N-propylnorapomorphine, Eur. J. Pharmac., 56, 291, 10.1016/0014-2999(79)90187-0
Titeler, 1977, New detection of brain dopamine receptors with 3H-dihydroergocryptine, 74, 3750
Titeler, 1978, Multiple receptors for brain dopamine, 75, 1153
Trabucchi, 1976, Effects of bromocriptine on central dopaminergic receptors, Life Sci., 19, 225, 10.1016/0024-3205(76)90394-5
U'Prichard, 1977, Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors, Molec. Pharmac., 13, 454
Uzumaki, 1982, Effects of GTP and sodium on rat striatal dopamine receptors labeled with lisuride, Brain Res., 248, 185, 10.1016/0006-8993(82)91162-3
Van Rossum, 1966, The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs, Arch. int. Pharmacodyn. Ther., 160, 492
Vincent, 1980, Synthesis of [82Br]Bromperidol and preliminary tissue distribution studies in the rat, J. Med. Chem., 23, 75, 10.1021/jm00175a014
Watanabe, 1985, Regulation of anterior pituitary D2 dopamine receptors by magnesium and sodium ions, J. Neurochem., 45, 1842, 10.1111/j.1471-4159.1985.tb10542.x
Watanabe, 1985, Dependence of dopamine receptor conversion from agonist high- to low-affinity state on temperature and sodium ions, Biochem. Pharmac., 34, 2459, 10.1016/0006-2952(85)90526-X
Watling, 1982, Inhibition of postsynaptic dopamine-sensitive adenylate cyclase in carp retina by the putative dopamine autoreceptor agonist, 3-PPP, Eur. J. Pharmac., 82, 117, 10.1016/0014-2999(82)90565-9
Watling, 1982, Interaction of the putative dopamine autoreceptor agonists, 3-PPP and TL-99, with the dopamine-sensitive adenylate cyclase of carp retina, Eur. J. Pharmac., 77, 321, 10.1016/0014-2999(82)90136-4
Weinstock, 1980, Separation of potent central and renal dopamine agonist activity in substitute 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1-H-3-benzazepines, J. Med. Chem., 23, 973, 10.1021/jm00183a001
Weiss, 1985, D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture, Molec. Pharmacol., 27, 595
Welch, 1983, Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor, Life Sci., 33, 1687, 10.1016/0024-3205(83)90725-7
Whitaker, 1977, Hallucinogen binding to dopamine/neuroleptic receptors, J. Pharm. Pharmac., 29, 506, 10.1111/j.2042-7158.1977.tb11381.x
Whitaker, 1979, Selective labeling of apomorphine receptors by 3H-LSD, Eur. J. Pharmac., 56, 269, 10.1016/0014-2999(79)90182-1
Willems, 1985, Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system, Pharmac. Rev., 37, 165
Wong, 1980, Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains, Res. Commun. Chem. Path. Pharmac., 30, 195
Wong, 1984, Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain, Science, N.Y., 226, 1393, 10.1126/science.6334363
Woodruff, 1971, Dopamine receptors: A review, Comp. Gen. Pharmac., 2, 439, 10.1016/0010-4035(71)90041-3
Woodruff, 1978, Biochemical and pharmacological studies on dopamine receptors, Adv. Biochem. Psychopharmac., 19, 89
Wouters, 1984, Photoaffinity labelling of dopamine receptors, 145, 273
Wreggett, 1984, The ternary complex model, 26, 214
Wreggett, 1984, Agonist high- and low-affinity states of the D2 dopamine receptor in calf brain: partial conversion by guanine nucleotide, Molec. Pharmac., 25, 10